Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release

Journal of Neurotrauma

Volumn 14, Issue 3, 1997, Pages 161-169

  Dixon, C Edward ^a,b   Ma, Xiecheng ^a   Marion, Donald W ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b 201 Hill Building ^*  (United States)

Author keywords

acetylcholine; behavior; microdialysis; rats; traumatic brain injury; water maze

Indexed keywords

ACETYLCHOLINE; CITICOLINE; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE; SODIUM CHLORIDE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MICRODIALYSIS; MOTOR PERFORMANCE; NEOCORTEX; NONHUMAN; RAT; SPATIAL MEMORY;

EID: 0030907699     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1997.14.161     Document Type: Article

References (41)

1. AGUT, J., G.-COVIELLA, L., ORTIZ, J.A., and WURTMAN, R.J. (1993). Oral cytidne 5 ′-diphosphate choline administration to rats increases phospholipid levels. Ann. NY Adac. Sci. 695, 318-320.
2. ALTHAUS, J.S., ANDRUS, P.K., WILLIAMS, C.M., VONVOIGTLANDER, P.F., CAZERS, A.R., et al. (1993). The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Mol. Chem. Neuropath. 20, 147-162.
3. CACABELOS, R., ALVAREZ, X.A., FRANCO-MASIDE, A., FERNANDEZ-NOVOA, L., and CAAMANO, J. (1994). Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia. Ann. NY Acad. Sci. 16, 211-218.
4. CLIFTON, G.L., JIANG, J.Y., LYETH, B.G., JENKINS, L.W., HAMM, R.J., et al. (1991). Marked protection by moderate hypothermia after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 11, 114-121.
5. th ed. New York: Oxford University Press.
6. DIETRICH, W.D., ALONSO, O., BUSTO, R., and FINKLESTEIN, S.P. (1996). Posttreatment with intravenous basic fibroblast growth factor reduces histopathological damage following fluid-percussion brain injury in rats. J. Neurotrauma 13, 309-316.
7. DIETRICH, W.D., ALONSO, O., BUSTO, R., GLOBUS, M.Y.T., and GINSBERG, M.D. (1994). Post-traumatic brain hypothermia reduces histopathological damage following concussive brain injury in the rat. Acta Neuropathol. 87, 250-258.
8. DIXON, C.E., BAO, J., LONG, D.A., and HAYES, R.L. (1996a). Reduced evoked release of acetylcholine in the rodent hippocampus following traumatic brain injury. Pharm. Biochem. and Behav. 53, 679-686.
9. DIXON, C.E., MA, X., and MARION, D.W. (1996b). Reduced evoked release of acetylcholine in the rodent neocortex following traumatic brain injury. Brain Res. (in press).
10. DIXON, C.E., FLINN, P., BAO, J., YANG, K., WHITSON, J., et al. (1995). Nerve growth factor (NGF) reduces decreases in spatial memory performance and choline acetyltransferase (ChAT) immunoreactivity in the medial septal area following traumatic brain injury. Proceed. Soc Neurosci. Annual Meeting. Soc. Neurosci. Abstr. 21 (1), 762.
11. DIXON, C.E., HAMM, R.J., TAFT, W.C., and HAYES, R.L. (1994). Increased anticholinergic sensitivity following closed skull impact and controlled cortical impact traumatic brain injury in the rat. J. Neurotrauma 11, 275-287.
12. DIXON, C.E., CLIFTON, G.L., LIGHTHALL, L.W., YAGHMAI, A.A., and HAYES, R.L. (1991). A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Meth. 39, 253-262.
13. D'ORLANDO, K.J., and SANDAGE, B.W., JR. (1995). Citicoline (CDP-choline): mechanism of action and effects in ischemic brain injury. Neurol. Res. 17, 281-284.
14. FADEN, A.I., DEMEDIUK, P., PANTER, S.S., and VINK, R. (1988). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 798-800.
15. FEENEY, D.M., GONZALEZ, A., and LAW, W.A. (1982). Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217, 855-857.
16. GORMAN, L.K., FU, K., HOVDA, D.A., MURRAY, M., and TRAYSTMAN, R.J. (1996). Effects of traumatic brain injury on the cholinergic system in the rat. J. Neurotrauma 13, 457-463.
17. HAMM, R.J., WHITE-GBADEBO, D.M., LYETH, B.G., JENKINS, L.W., and HAYES, R.L. (1992). The effect of age on motor and cognitive deficits after traumatic brain injury in rats. Neurosurg. 31, 1072-1078.
18. HAYES, R.L., JENKINS, L.W., LYETH, B.G., BALSTER, R.L., ROBINSON, S.E., et al. (1988). Pretreatment with phencyclidine, an N-methyl-D-aspartate receptor antagonist, attenuates long-term behavioral deficits in the rat produced by traumatic brain injury. J. Neurotrauma 5, 259-274.
19. JACKSON, D.A., KISCHKA, U., and WURTMAN, R.J. (1995). Choline enhances scopolamine-induced acetylcholine release in dorsal hippocampus of conscious, freelymoving rats. Life Sci. 56, 45-49.
20. KAKIHANA, M., FUKUDA, N., SUNO, M., and NAGAOKA, A. (1988). Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke 19, 217-222.
21. KENNEDY, E.P., and WEISS, S.B. (1956). The function of cytidine coenzymes in the biosynthesis of phospholipids. J. Biol. Chem. 222, 193-214.
22. LEONARD, J.R., MARIS, D.O., and GRADY, M.S. (1994). Fluid percussion injury causes loss of forebrain choline acetyltransferase and nerve growth factor receptor immunoreactive cells in the rat. J. Neurotrauma 11, 379-392.
23. LEVIN, H.S. (1991). Treatment of postconcussional symptoms with CDP-choline. J. Neurol. Sci. 103, S39-S42.
24. LEVIN, H.S., ALDRICH, E.F., SAYDJARI, C., EISENBERG, H.M., FOULKES, M.A., et al. (1992). Severe head injury in children: Experience of the traumatic coma data bank. Neurosurg 31, 435-444.
25. LONG, D.A., GHOSH, K., MOORE, A.N., DIXON, C.E., and DASH, P.K. (1996). Deferoxamine improves spatial memory performance following experimental brain injury in rats. Brain Res. 717, 109-117.
26. LOPEZ-COVIELLA, I., AGUT, J., SAVCI, V., ORTIZ, J.A., and WURTMAN, R.J. (1995). Evidence that 5′-cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levels. J. Neurochem. 65, 889-894.
27. LYETH, B.G., DIXON, C.E., HAMM, R.J., JENKINS, L.W., YOUNG, H.F., et al. (1988). Effects of anticholinergic treatment on transient behavioral suppression and physiological responses following concussive brain injury to the rat. Brain Res. 448, 88-97.
28. MARION, D.W., and WHITE, M. (1996). Combination therapy for experimental traumatic brain injury. J. Neurotrauma 13, 139-147.
29. MARSHALL, D.L., and WURTMAN, R.J. (1993). Effects of choline on basal and stimulated acetylcholine release: an in vivo microdialysis study using a low neostigmine concentration. Brain Res. 269, 269-274.
30. McINTOSH, T.K. (1993). Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: A review. J. Neurotrauma 10, 215-261.
31. McINTOSH, T.K., THOMAS, M., SMITH, D., and BANBURY, M. (1992). The novel 21-aminosteroid U74006F attenuates cerebral edema and improves survival after brain injury in the rat. J. Neurotrauma 9, 33-46.
32. O'DELL, D.M., and HAMM, R.J. (1995). Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABBA receptor, and cognitive impairment in rats following traumatic brain injury. J. Neurosurgery 83, 878-883.
33. PETKOV, V.D., KEHAYOV, R.A., MOSHARROF, A.H., PETKOV, V.V., GETOVA, D., et al. (1993). Effects of cytidine diphosphate choline on rats with memory deficits. Drug Res. 43, 822-828.
34. PIKE, B.R., and HAMM, R.J. (1995). Postinjury administration of BIBN 99, A selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats. Brain Res. 686, 37-43.
35. PLENGER, P.M., DIXON, C.E., CASTILLO, R.M., FRANKOWSKI, R.F., YABLON, S.A., et al. (1996). Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: A preliminary double-blind placebo-controlled study. Arch. Phys. Med. Rehabil. 77, 536-540.
36. SAATMAN, K.E., MURAI, H., BARTUS, R.T., SMITH, D.H., HAYWARD, N.J., et al. (1996). Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc. Natl. Acad. Sci. 93, 3428-3433.
37. SCHMIDT, R.H., and GRADY, M.S. (1995). Loss of forebrain cholinergic neurons following fluid-percussion injury: Implications for cognitive impairment in closed head injury. J. Neurosurg. 83, 496-502.
38. SINSON, G., VODDI, M., and MCINTOSH, T.K. (1995). Nerve growth factor administration attenuates cognitive but not neurobehavioral motor dysfunction or hippocampal cell loss following fluid-percussion brain injury in rats. J. Neurosurg. 65, 2209-2216.
39. SMITH, D.H., OKIYAMA, K., THOMAS, M.J., and MCINTOSH, T.K. (1993). Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury. J. Neurosci. 13, 5383-5392.
40. VILLA, R.F., INGRAO, F., MAGRI, G., GORINI, A., REALE, S., et al. (1993). Effect of CDP-choline treatment on mitochondrial and synaptosomal protein composition in different brain regions during aging. Int. J. Devl. Neurosci. 11, 83-93.
41. YOSHINO, A., HOVDA, D., KAWAMATA, T., KATAYAMA, Y., and BECKER, D. (1991). Dynamic changes in local cerebral glucose utilization following cerebral concussion: Evidence of a hyper- and subsequent hypometabolic state. Brain Res. 561, 106-119.